Published July 2018
| Version v1
Journal article
The optimal TSH level necessary for successful radioiodine ablation of differentiated thyroid carcinoma, as well as the time to reach this level, is a work in progress
- 1. University of Pretoria and Steve Biko Academic Hospital, Department of Nuclear Medicine, Pretoria (South Africa)
- 2. University Medical Center Groningen, University of Groningen, Department of Nuclear Medicine and Molecular Imaging, Groningen (Netherlands)
Description
no abstract available
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00259-018-3999-yAdditional details
Identifiers
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 45
- Journal Issue
- 7
- Journal Page Range
- p. 1270-1271
- ISSN
- 1619-7070
- CODEN
- EJNMA6
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 49060436
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- No Abstract, Numerical Data
- Descriptors DEI
- ABLATION; CARCINOMAS; COMPILED DATA; IODINE 131; MULTIVARIATE ANALYSIS; RADIOPHARMACEUTICALS; SIZE; SURGERY; SURVIVAL CURVES; SURVIVAL TIME; THYROID; THYROID HORMONES
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; DATA; DAYS LIVING RADIOISOTOPES; DISEASES; DRUGS; ENDOCRINE GLANDS; GLANDS; HORMONES; INFORMATION; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; MATHEMATICS; MEDICINE; NEOPLASMS; NUCLEI; NUMERICAL DATA; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; ORGANS; PEPTIDE HORMONES; PROTEINS; RADIOACTIVE MATERIALS; RADIOISOTOPES; STATISTICS